We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Beike Biotech and China’s Tsinghua University Receive USD $4 Million for Stem Cell

News   Nov 14, 2007

 
Beike Biotech and China’s Tsinghua University Receive USD $4 Million for Stem Cell
 
 
 

RELATED ARTICLES

Targeting a Protease To Treat Inflammatory Bowel Disease

News

The protease MT1-MMP could be a possible future target for drugs to treat inflammatory bowel disease (IBD) according to a new study.

READ MORE

Ribosome-based Treatments: A Sought After Therapy Option for Orphan Diseases?

News

Recently, Urania Therapeutics announced that it has successfully raised €3.53M ($3.89M) in seed funding to unlock the therapeutic potential of ribosome-based treatments. We spoke with Jean-Paul Renaud, President and CSO of Urania Therapeutics, to learn more about the mechanisms of readthrough compounds and how the company hopes to provide treatment solutions for orphan diseases.

READ MORE

Wrinkles on the Skin of a Worm May Hold the Key to a Longer, Healthier Life for Humans

News

Working with Caenorhabditis elegans, a transparent nematode found in soil, researchers were the first to find that the nervous system controls the tiny worm's cuticle, a skin-like exterior barrier, in response to bacterial infections.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE